KalVista Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q2 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
KalVista Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q2 2019 to Q1 2024.
  • KalVista Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending April 30, 2024 was $1.68M, a 27.5% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.68M -$637K -27.5% Apr 30, 2024 10-K 2024-07-11
Q1 2023 $2.31M -$453K -16.4% Apr 30, 2023 10-K 2023-07-10
Q1 2022 $2.77M +$815K +41.8% Apr 30, 2022 10-K 2022-07-07
Q2 2021 $2.45M +$2.12M +640% Jul 31, 2021 10-Q 2021-09-09
Q1 2021 $1.95M +$1.57M +415% Apr 30, 2021 10-K 2021-07-13
Q4 2020 $349K +$35K +11.1% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 $335K -$8K -2.33% Oct 31, 2020 10-Q 2020-12-10
Q2 2020 $331K -$34K -9.32% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $379K Apr 30, 2020 10-K 2020-07-01
Q4 2019 $314K Jan 31, 2020 10-Q 2020-03-10
Q3 2019 $343K Oct 31, 2019 10-Q 2019-12-03
Q2 2019 $365K Jul 31, 2019 10-Q 2019-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.